Skip to content
GLP-1 Scorecard
Menu
Graded #271

Society of You

Society of You is a US telehealth brand (Society Management Group) offering compounded GLP-1 weight-loss medication filled through named partner pharmacies (Emerald and Striker).

Visit Society of YouWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$279/mo (promotional rate, compounded)
Tirzepatide
$425/mo (compounded)
Coverage
Coverage not published
Brand-name
Yes

Weigh Society of You against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value39/100
Dose & formulation88/100
Clinical oversight75/100
Labs & monitoring52/100
Fulfillment65/100
Contract terms55/100

Strengths

  • Two named partner pharmacies disclosed (Emerald Pharmacy, Striker Pharmacy)
  • Injectable and oral tirzepatide plus semaglutide options
  • Discounted first-month introductory pricing

Where it loses points

  • Standard rates are high once the intro month ends ($279-$425/mo)
  • Service-area states are not published on the marketing site
  • Support details are not disclosed publicly

Bottom line — Grade C

Best for: Shoppers who want compounded GLP-1 from named partner pharmacies, including oral tirzepatide.

Ranked #271 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Society of You — the realistic shortlist.

The 20 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Society of You's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Society of You's site. Not medical advice; see our disclosure.

← Back to the scorecard